Laboratory-induced cue reactivity among individuals with prescription opioid dependence
Open accessAbstract
Prescription opioid (PO) dependence is a critical health problem. Although examination of drug cue reactivity paradigms has advanced the understanding of risk factors for relapse for a variety of substances (e.g., cocaine, alcohol, nicotine), no PO specific drug cue paradigm has been developed. The current study addressed this gap in the literature and evaluated the ability of a newly developed PO drug cue paradigm to elicit subjective, physiological, and neuroendocrine changes among PO-dependent participants (n = 20) as compared to controls (n = 17). The drug cue paradigm included an induction script, viewing and handling paraphernalia (e.g., bottle of oxycontin pills, pill crusher) and watching a video depicting people using POs as well as places related to POs (e.g., pharmacies). Consistent with hypotheses, the PO group demonstrated significant pre- to post-cue increases on subjective ratings of craving, difficulty resisting POs, stress, and anger. The control group did not demonstrate significant changes on any of the subjective measures. Both the PO group and the control group evidenced significant pre- to post-cue increases in physiological responses (e.g., blood pressure, skin conductance), as expected given the arousing nature of the drug cue stimuli. The PO group, but not the control group, evidenced a significant pre- to post-cue increase in heart rate and salivary cortisol levels. The development and validation of a drug cue paradigm for POs may help inform future research and treatment development efforts for patients with PO dependence.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 27 cited sources checked · 0 supported · 0 flagged
- Findingown data
Control participants did not show significant pre- to post-cue changes on any subjective rating.
“The control group did not demonstrate significant changes on any of the subjective measures.”
Quote in the paperSubstantial claim - Findingown data
In participants with prescription opioid dependence, the drug cue paradigm produced a significant increase from pre-cue to post-cue in stress.
“the PO group evidenced significant pre- to post-cue changes on subjective ratings of craving (Figure 1), stress (Figure 2), difficulty resisting use, and anger (ts > 2.8; ps < .05).”
Quote in the paperSubstantial claim - Findingown data
Both participants with prescription opioid dependence and controls showed a significant increase from pre-cue to post-cue in mean arterial pressure in response to the drug cue.
“Both the PO and control groups demonstrated increased MAP and GSR in response to the drug cue (ts > 4.9; ps < .01).”
Quote in the paperSubstantial claim - Findingown data
In participants with prescription opioid dependence, the drug cue paradigm produced a significant increase from pre-cue to post-cue in anger.
“the PO group evidenced significant pre- to post-cue changes on subjective ratings of craving (Figure 1), stress (Figure 2), difficulty resisting use, and anger (ts > 2.8; ps < .05).”
Quote in the paperSubstantial claim - Findingown data
Participants with prescription opioid dependence, but not controls, showed a significant increase from pre-cue to post-cue in heart rate in response to the drug cue.
“The PO group, but not the control group, evidenced a significant pre- to post-cue increase in heart rate and salivary cortisol levels.”
- Also stated in: § Effects of Drug Cue on Physiological Reactivity · boosted
“However, the PO group (t = 3.3, p < .01), but not the control group (t = 1.9; p > .05), demonstrated increased HR in response to the drug cue. This HR finding was further supported by a significant group effect on post-cue HR in the ANCOVA (F = 4.4; p < .05).”
Quote in the paperSubstantial claim - Also stated in: § Effects of Drug Cue on Physiological Reactivity · boosted
- Findingown data
In participants with prescription opioid dependence, the drug cue paradigm produced a significant increase from pre-cue to post-cue in craving.
“the PO group evidenced significant pre- to post-cue changes on subjective ratings of craving (Figure 1), stress (Figure 2), difficulty resisting use, and anger (ts > 2.8; ps < .05).”
Quote in the paperSubstantial claim - Findingown data
Participants with prescription opioid dependence, but not controls, showed a significant increase from pre-cue to post-cue in salivary cortisol in response to the drug cue.
“The PO group, but not the control group, evidenced a significant pre- to post-cue increase in heart rate and salivary cortisol levels.”
- Also stated in: § Effects of Drug Cue on Neuroendocrine Response · boosted
“In response to the drug cue paradigm the PO group, but not the control group, demonstrated a significant pre- to post-cue increase in cortisol (t = 2.3; p < .05). An ANCOVA was run for cortisol levels across the two groups (PO vs. control) with the pre-cue scores entered as covariates. A significant group effect on post-cue cortisol was revealed (F = 5.6; p < .05; Figure 3).”
Quote in the paperSubstantial claim - Also stated in: § Effects of Drug Cue on Neuroendocrine Response · boosted
- Findingown data
In participants with prescription opioid dependence, the drug cue paradigm produced a significant increase from pre-cue to post-cue in difficulty resisting prescription opioids.
“the PO group evidenced significant pre- to post-cue changes on subjective ratings of craving (Figure 1), stress (Figure 2), difficulty resisting use, and anger (ts > 2.8; ps < .05).”
Quote in the paperSubstantial claim - Findingown data
Both participants with prescription opioid dependence and controls showed a significant increase from pre-cue to post-cue in galvanic skin response in response to the drug cue.
“Both the PO and control groups demonstrated increased MAP and GSR in response to the drug cue (ts > 4.9; ps < .01).”
Quote in the paperSubstantial claim - Findingown data
At baseline, heart rate and galvanic skin response were higher in the prescription-opioid group than in controls.
“Consistent with expectations, HR and GSR indices were higher at baseline among the PO than control group.”
Quote in the paperNot a substantial claim - Findingown data
Control participants' cortisol levels decreased slightly from before to after cue exposure.
“Among the control group, cortisol levels decreased slightly from pre- to post-cue administration.”
Quote in the paperNot a substantial claim - Findingown data
Contrary to the hypothesis, only heart rate response was significantly larger in the prescription-opioid group than in controls.
“Contrary to our hypothesis, only the HR response among the PO group was significantly greater than the amount of response observed among the control group.”
Quote in the paperSubstantial claim - Findingcitation
The subjective responses had moderate to large effect sizes.
“The moderate to large effect sizes for these subjective responses are consistent with prior cue reactivity research and suggest that subjective ratings are especially sensitive to the specificity of the cues administered (Carter & Tiffany, 1999).”
Quote in the paperSubstantial claim - Findingown data
The newly created prescription-opioid cue paradigm produces different subjective and biological reactions in people dependent on prescription opioids compared with healthy controls.
“Results indicate that the newly developed PO drug cue paradigm effectively elicits differential subjective and biological responses among PO dependent individuals as compared to healthy controls.”
Quote in the paperSubstantial claim - Findingown data
Only the prescription-opioid-dependent group had a significant increase in salivary cortisol from before to after cue exposure.
“As hypothesized, only the PO dependent group evidenced a significant pre- to post-cue salivary cortisol increase.”
Quote in the paperSubstantial claim - Study design and conductown data
At baseline, participants with prescription opioid dependence had significantly higher mean arterial pressure and heart rate than controls.
“The findings demonstrated significantly higher MAP and HR in the PO group compared to the control group (Fs > 3.9; ps ≤ .05).”
Quote in the paperNot a substantial claim - Study design and conductcitation
Focus groups with 24 individuals with prescription opioid dependence were used to develop the multi-modal prescription opioid drug cue paradigm.
“Thus, we conducted focus groups (N=24) with individuals with PO dependence to inquire about what types of stimuli or places trigger cravings to use POs and incorporated that information into the development of a multi-modal PO drug cue paradigm (Back et al., 2011).”
Quote in the paperSubstantial claim - Premisecitation
Cue reactivity measured in the laboratory predicts relapse to drug use outside the laboratory among individuals dependent on cocaine or nicotine.
“Importantly, cue reactivity in the laboratory has been found to predict relapse to drug use outside of the laboratory among cocaine and nicotine-dependent individuals (Back et al., 2010; Sinha et al., 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
Subjective ratings are particularly sensitive to how specific the cues are.
“The moderate to large effect sizes for these subjective responses are consistent with prior cue reactivity research and suggest that subjective ratings are especially sensitive to the specificity of the cues administered (Carter & Tiffany, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Carter & Tiffany, 1999
Not checked in the free run.
- Premisecitation
Cue reactivity paradigms have been useful for predicting substance use behaviors, including self-initiated abstinence, latency to use, and relapse, in various substance-dependent populations.
“Further, these paradigms have demonstrated utility in predicting substance use behaviors – including self-initiated abstinence, latency to use, and relapse – among a variety of substance dependent populations (Conklin, Parzynski, Salkeld, Perkins, & Fonte, 2012; Fatseas et al., 2011; Garland, Carter, Ropes, & Howard, 2012; Shiffman et al., 2013).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Physiological responses matched earlier cue reactivity findings in heroin-dependent people.
“Responses were also consistent with prior cue reactivity research among heroin dependent individuals (Behera, Goswami, Khastiger, & Kumar, 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Behera, Goswami, Khastiger, & Kumar, 2003
Not checked in the free run.
- Interpretationreasoning
Because the prescription-opioid group was not treatment-seeking, the findings may not generalize to treatment-seeking individuals.
“In addition, the PO group was comprised of non-treatment seeking individuals. As such, the findings may not be generalizable to treatment-seeking individuals.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The cue reactivity paradigm developed and validated in this study is a tool with potential empirical and clinical utility for addressing prescription opioid dependence.
“The cue reactivity paradigm developed and validated by the current study is one such tool with the potential for empirical and clinical utility to address the problem of PO dependence.”
Quote in the paperSubstantial claim- Rests on an assumption: Prescription opioid misuse, abuse, and dependence are epidemic and increasing.
- Interpretationcitation
Physiological responses largely matched the incentive or appetitive-motivational model, which expects cue reactivity to align with the drug's effect.
“With regard to physiological indices of reactivity, responses were largely consistent with the incentive or appetitive-motivational model which predicts that cue reactivity will be congruent with the drug effect (Stewart, deWit, & Eikelboom, 1984).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stewart, deWit, & Eikelboom, 1984
Not checked in the free run.
- Interpretationreasoning
The control group's increase in physiological response may be explained by the arousing nature of some parts of the drug cue paradigm.
“The increase in physiological response among control participants may be attributed to the arousing nature of some elements of the drug cue paradigm.”
Quote in the paperSubstantial claim
- May combine two claims. 16
- Classified as probably not a substantial claim. 10
May combine two claims.
Findingown dataThe new paradigm produced negative affect as well as craving in prescription-opioid-dependent participants.
“Subjective results also show that the newly developed paradigm elicited negative affect in addition to craving among PO dependent individuals.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataControl participants' stress, anger, and sadness either decreased or did not change after cue exposure.
“Stress, anger, and sadness either improved or stayed the same following cue administration among controls.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth prescription-opioid and control participants had significant increases in mean arterial pressure and galvanic skin response from before to after cue exposure.
“Participants in both the PO and control group demonstrated significant pre- to post-cue increases in MAP and GSR.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt baseline, prescription-opioid-dependent participants reported more negative affect, such as stress and anger, and more craving than controls.
“At baseline, PO dependent individuals presented with significantly more negative affect (e.g., stress, anger) and craving.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFrom before to after cue exposure, prescription-opioid-dependent participants had larger increases than controls in craving, stress, anger, and inability to resist using.
“As expected, the PO group evidenced significantly greater increases in pre- to post-cue craving, stress, anger, and inability to resist using in response to the drug cue paradigm compared to the control group.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn a treatment-seeking sample of individuals with prescription opioid dependence, 74% had relapsed by week 16 and 91% by week 24.
“At week 16, 74% of participants had relapsed and by week 24, 91% had relapsed.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Weiss et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationExposure to drug-related cues, compared with neutral cues, increases craving and produces changes in mood and physiological measures.
“Previous laboratory studies have shown that exposure to drug-related cues, as compared to neutral cues, increases craving and induces changes in mood states and physiological measures (Carter & Tiffany, 1999; Shi et al., 2009; Yu et al., 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Carter & Tiffany, 1999
Not checked in the free run.
- cites Shi et al., 2009 source
Not checked in the free run.
- cites Yu et al., 2007
Not checked in the free run.
May combine two claims.
Study design and conductown dataAt baseline, participants with prescription opioid dependence had higher subjective ratings than controls for stress, craving, difficulty resisting use, anger, willingness to pay to use, and state anxiety, and lower happiness.
“These findings demonstrated significantly higher subjective ratings for stress (Figure 1), craving (Figure 2), difficulty resisting use, anger, amount willing to pay to use, and state anxiety (STAI) as well as significant lower happiness in the PO group compared to the control group (Fs > 3.9; ps < .055).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataSalivary cortisol was assayed in duplicate using a high-sensitivity enzyme immunoassay with an intra-assay coefficient of variation of 3.35% to 3.65% and a sensitivity below 0.003 ug/dL.
“Samples were assayed in duplicate using a high sensitivity salivary cortisol enzyme immunoassay system that has an intra-assay precision (coefficient of variation, CV) of 3.35% – 3.65% with a sensitivity of <0.003 ug/dL (Salimetrics LLC).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationConditioned stimuli play a critical role in maintaining drug-seeking behavior and relapse after periods of abstinence.
“Thus, conditioned stimuli play a critical role in sustaining ongoing drug-seeking behavior and relapse after periods of abstinence (Childress et al., 1988; O’Brien et al., 1998; Sinha et al., 2000; Stewart, 2003).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Childress et al., 1988
Not checked in the free run.
- cites O’Brien et al., 1998
Not checked in the free run.
- cites Sinha et al., 2000 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductreasoningParticipants were admitted to the hospital overnight before testing to control for extraneous variables such as sleep and caffeine intake that could affect reactivity.
“Participants were admitted to the hospital at 2000h the evening prior to testing to allow for the control of extraneous variables (e.g., sleep, caffeine intake) that could potentially affect reactivity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe prescription opioid and control groups differed in education and employment status, but no other demographic differences were observed.
“As expected, two-variable χ2 tests revealed group differences in education and employment status (χ2s > 4.9; ps < .05). No other demographic differences were observed.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThree days of abstinence from alcohol and other substances, except caffeine and nicotine, were required before admission and verified by self-report, breathalyzer, and urine drug screen.
“Three days of abstinence from alcohol and other substances (except caffeine and nicotine), as evidence by self-report, breathalyzer and urine drug screen, were required prior to admission for the overnight stay.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataAt baseline, participants with prescription opioid dependence had higher Addiction Severity Index subscale scores for drug use, legal status, and psychiatric symptoms than controls.
“One-way analyses of variance (ANOVA) revealed significantly higher ASI subscale scores for drug use, legal status, and psychiatric symptoms among the PO group, as compared to controls (Fs > 6.2; ps < .05).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningHPA measures were consistent with participants' subjective and physiological responses, which supports the validity of the drug cue paradigm.
“Further, these findings suggest that measures of HPA function were consistent with participants’ subjective and physiological responses, lending further support to the validity of the drug cue paradigm developed here.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCue reactivity paradigms have been used successfully to identify neural substrates and networks involved in craving for nicotine, cocaine, and alcohol.
“As an example of potential future applications for the current paradigm, cue reactivity paradigms have been successfully used to elucidate neural substrates and networks implicated in the craving response for an array of substances including nicotine, cocaine, and alcohol (Cunningham & Anastasio, 2013; Engelmann et al., 2012; Lou et al., 2012; Mainz et al., 2012; Schacht, Anton, & Myrick, 2013),”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNegative affect and craving predict relapse in other substance-dependent groups.
“These responses are often identified as interrelated (Schlauch, Gwynn-Shapiro, Stasiewicz, Molnar, & Lang, 2013) and are consistent predictors of relapse among other substance dependent populations (Hendershoot, Witkiewitz, George, & Marlatt, 2011; Li et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Hendershoot, Witkiewitz, George, & Marlatt, 2011
Not checked in the free run.
- cites Li et al., 2012
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCue reactivity paradigms have made major contributions to addiction research across alcohol, cocaine, heroin, and nicotine.
“Cue reactivity paradigms have contributed significantly to advancements in addictions research for a variety of substances, including alcohol, cocaine, heroin, and nicotine (Carter & Tiffany, 1999a,b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Carter & Tiffany, 1999a,b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNegative affect and craving are often considered interrelated.
“These responses are often identified as interrelated (Schlauch, Gwynn-Shapiro, Stasiewicz, Molnar, & Lang, 2013) and are consistent predictors of relapse among other substance dependent populations (Hendershoot, Witkiewitz, George, & Marlatt, 2011; Li et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schlauch, Gwynn-Shapiro, Stasiewicz, Molnar, & Lang, 2013
Not checked in the free run.
May combine two claims.
PremisecitationIn earlier drug cue paradigm studies, post-cue cortisol increases indicate a stress response that correlates with drug craving and predicts future relapse.
“In prior drug cue paradigm research, post-cue elevations in cortisol have been found to be indicative of a stress response that is correlated with drug craving, and predictive of future relapse (Back et al., 2010; Fatseas et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningDeveloping and validating a prescription-opioid-specific cue paradigm has potential to extend drug abuse research to prescription opioid use disorders.
“The development and validation of a PO-specific cue paradigm has potential utility in extending advances in drug abuse research to the study of PO use disorders.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNormative IAPS data indicate that pictures of drug-related behaviors and cocaine paraphernalia receive moderate arousal ratings and are therefore likely to arouse most participants, including non-using healthy controls.
“In fact, normative data on the International Affective Picture System (Lang, Ohman, & Vaitl, 1988), involving a wide range of affective pictures with valence and arousal ratings, suggest that pictures of drug related behaviors and cocaine paraphernalia receive moderate arousal ratings”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Lang, Ohman, & Vaitl, 1988
Not checked in the free run.
- cites Cuthbert, Bradley, & Lang, 1996
Not checked in the free run.
May combine two claims.
InterpretationcitationBecause all participants had abstained from prescription opioids for at least three days, mild withdrawal symptoms may have affected reactivity.
“All participants had abstained from PO use for at least three days prior to their participation in the study. Acute abstinence has been noted as limitation of cue paradigms for other substances (e.g., Adams & Munafo, 2013); experience of mild PO withdrawal symptoms may have influenced reactivity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Adams & Munafo, 2013
Not checked in the free run.
The paper relies on this without support.
No studies have examined cue reactivity among individuals with prescription opioid dependence, and no prescription opioid-specific drug cue paradigm has been developed.
“To our knowledge, there have not been any studies examining cue reactivity among individuals with PO dependence. This critical gap in the literature is likely due to the fact that no drug cue paradigm for POs has been developed.”
The paper relies on this without support.
The study is the first to develop and validate a cue paradigm specific to prescription opioids.
“To our knowledge, this is the first study to develop and validate a drug cue paradigm specific to prescription opioids; that is, containing triggers that are directly address POs (e.g., a bottle of opioid pills, images of pharmacies, handling a pill crusher).”
The paper relies on this without support.
Prescription opioid misuse, abuse, and dependence are epidemic and increasing.
“In light of the continuing epidemic rise in misuse, abuse, and dependence on POs, the development of cue reactivity paradigms that are specific to POs is needed to help enhance assessment, treatment and relapse prevention.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Exposure to drug-related cues mediates symptoms of craving in opioid use disorder and may be linked with increased cortisol responses.
“Exposure to drug-related cues mediates the symptoms of craving in OUD (44–49) and may be linked with increased cortisol responses (50), consistent with the neuroendocrine underpinnings of craving as described in Figure 2 .”
From Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure numbers for stress and craving are reversed
MinorThe results first identify Figure 1 as stress and Figure 2 as craving, then assign those figure numbers the other way around.
“stress (Figure 1), craving (Figure 2)”
“craving (Figure 1), stress (Figure 2)”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
(1970) · Cited by 24,983 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
(1998) · PubMed · Cited by 10,216 · see citing works
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,882 · see citing works
Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531 · see citing works
Meta‐analysis of cue‐reactivity in addiction research
Carter, B. L., & Tiffany, S. T. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9433273.x · Cited by 1,638 · see citing works
Stewart, J., de Wit, H., & Eikelboom, R. (1984) · Psychological Review · doi:10.1037//0033-295x.91.2.251 · Cited by 1,064 · see citing works
Stewart, J., de Wit, H., & Eikelboom, R. (1984) · Psychological Review · doi:10.1037/0033-295x.91.2.251 · Cited by 1,062 · see citing works
Relevance of cue reactivity to understanding alcohol and smoking relapse.
Niaura, R. S., Rohsenow, D. J., Binkoff, J. A., Monti, P. M., Pedraza, M., & Abrams, D. B. (1988) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.97.2.133 · Cited by 717 · see citing works
Conditioning factors in drug abuse: can they explain compulsion?
O’Brien, C. P., Childress, A. R., Ehrman, R. N., & Robbins, S. J. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200103 · Cited by 680 · see citing works
Schacht, J. P., Anton, R. F., & Myrick, H. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00464.x · Cited by 583 · see citing works
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540 · see citing works
Zacny, J. P., Bigelow, G. E., Compton, P. A., Foley, K. M., Iguchi, M. Y., & Sannerud, C. A. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00003-6 · Cited by 517 · see citing works
Trends in Medical Use and Abuse of Opioid Analgesics
Joranson, D. E. (2000) · JAMA · doi:10.1001/jama.283.13.1710 · Cited by 505 · see citing works
Relapse prevention for addictive behaviors
Hendershot, C. S., Witkiewitz, K., George, W. H., & Marlatt, G. A. (2011) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-6-17 · Cited by 467 · see citing works
Psychological stress, drug-related cues and cocaine craving
Sinha, R., Fuse, T., Aubin, L.-R., & O'Malley, S. S. (2000) · Psychopharmacology · doi:10.1007/s002130000499 · Cited by 463 · see citing works
The Addiction Severity Index at 25: Origins, contributions, and transitions
McLellan, A. T., Cacciola, J. C., Alterman, A. I., Rikoon, S. H., & Carise, C. (2006) · The American Journal on Addictions · doi:10.1080/10550490500528316 · Cited by 450 · see citing works
Probing picture perception: Activation and emotion
Cuthbert, B. N., Bradleym, M. M., & Lang, P. J. (1996) · Psychophysiology · doi:10.1111/j.1469-8986.1996.tb02114.x · Cited by 403 · see citing works
Drug poisoning deaths in the United States, 1980-2008.
Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Miniño, A. (2011) · PubMed · Cited by 399 · see citing works
Neural substrates of smoking cue reactivity: A meta-analysis of fMRI studies
Engelmann, J. M., Versace, F., Robinson, J. D., Minnix, J. A., Lam, C. Y., Cui, Y., Brown, V. L., & Cinciripini, P. M. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.024 · Cited by 394 · see citing works
Results from the 2006 National Survey on Drug Use and Health
(2007) · PsycEXTRA Dataset · doi:10.1037/e723702007-017 · Cited by 338 · see citing works
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336 · see citing works
Modeling stress and drug craving in the laboratory: implications for addiction treatment development
Sinha, R. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00134.x · Cited by 314 · see citing works
Childress, A. R., McLellan, A. T., & O’Brien, C. P. (1986) · British Journal of Addiction · doi:10.1111/j.1360-0443.1986.tb00385.x · Cited by 258 · see citing works
Neural substrates of conditioned-cued relapse to drug-seeking behavior
See, R. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00682-7 · Cited by 257 · see citing works
What does cue-reactivity have to offer clinical research?
Drummond, C. (2000) · Addiction · doi:10.1080/09652140050111708 · Cited by 248 · see citing works
Neural responses associated with cue evoked emotional states and heroin in opiate addicts
Sell, L., Morris, J. S., Bearn, J., Frackowiak, R. S. J., Friston, K. J., & Dolan, R. J. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00158-1 · Cited by 238 · see citing works
What does cue‐reactivity have to offer clinical research?
Drummond, C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.2.x · Cited by 215 · see citing works
Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence
Carroll, K. M., Ball, S. A., Nich, C., O’Connor, P. G., Eagan, D. A., Frankforter, T. L., Triffleman, E., Shi, J. M., & Rounsaville, B. J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.755 · Cited by 198 · see citing works
Facing up to the prescription opioid crisis
Dhalla, I. A., Persaud, N., & Juurlink, D. N. (2011) · BMJ · doi:10.1136/bmj.d5142 · Cited by 190 · see citing works
Daglish, M. R. C., Weinstein, A. M., Malizia, A. L., Wilson, S., Melichar, J., Britten, S., Brewer, C. L., Lingford-Hughes, A. R., Myles, J. S., Grasby, P. M., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1680 · Cited by 171 · see citing works
Applying laboratory research: Drug anticipation and the treatment of drug addiction.
Siegel, S., & Ramos, B. M. C. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.3.162 · Cited by 170 · see citing works
Gender Differences in Craving and Cue Reactivity to Smoking and Negative Affect/Stress Cues
Saladin, M. E., Gray, K. M., Carpenter, M. J., LaRowe, S. D., DeSantis, S. M., & Upadhyaya, H. P. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00232.x · Cited by 157 · see citing works
Environments as cues to smoke: Implications for human extinction-based research and treatment.
Conklin, C. A. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.1.12 · Cited by 154 · see citing works
Characteristics and correlates of men and women with prescription opioid dependence
Back, S. E., Lawson, K. M., Singleton, L. M., & Brady, K. T. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.03.013 · Cited by 150 · see citing works
Self-citationReactivity to laboratory stress provocation predicts relapse to cocaine
Back, S. E., Hartwell, K., DeSantis, S. M., Saladin, M., McRae-Clark, A. L., Price, K. L., Moran-Santa Maria, M. M., Baker, N. L., Spratt, E., Kreek, M. J., et al. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.016 · Cited by 148 · see citing works
Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations
Katz, N. P., Adams, E. H., Chilcoat, H. D., Colucci, R. D., Comer, S. D., Goliber, P., Grudzinskas, C. V., Jasinski, D. R., Lande, S. D., Passik, S. D., et al. (2007) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318125c5e8 · Cited by 144 · see citing works
Cue Reactivity and Effects of Cue Exposure in Abstinent Posttreatment Drug Users
Franken, I. H. A., de Haan, H. A., van der Meer, C. W., Haffmans, P. M. J., & Hendriks, V. M. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00004-x · Cited by 141 · see citing works
Conditioned craving and arousal in cocaine addiction: a preliminary report.
Childress, A. R., Ehrman, R. N., McLellan, A. T., & O'Brien, C. P. (1988) · PubMed · Cited by 138 · see citing works
Petróczi, A., & Nepusz, T. (2011) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-6-1 · Cited by 135 · see citing works
Li, Q., Wang, Y., Zhang, Y., Li, W., Yang, W., Zhu, J., Wu, N., Chang, H., Zheng, Y., Qin, W., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.024 · Cited by 133 · see citing works
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction
Cunningham, K. A., & Anastasio, N. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.030 · Cited by 131 · see citing works
Applying laboratory research: Drug anticipation and the treatment of drug addiction.
Siegel, S., & Ramos, B. M. C. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.162 · Cited by 123 · see citing works
Childress, A. R. (1986) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(86)90018-8 · Cited by 117 · see citing works
Pain Management, Controlled Substances, and State Medical Board Policy
Joranson, D. E., Gilson, A. M., Dahl, J. L., & Haddox, J. D. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00403-1 · Cited by 109 · see citing works
Compliance with Buprenorphine Medication‐Assisted Treatment and Relapse to Opioid Use
Tkacz, J. P., Severt, J. B., Cacciola, J., & Ruetsch, C. R. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00186.x · Cited by 105 · see citing works
Drug anticipation and drug addiction. The 1998 H. David Archibald Lecture
Siegel, S. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94811132.x · Cited by 102 · see citing works
Cue Reactivity in Alcohol and Tobacco Dependence
Drobes, D. J. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200212000-00026 · Cited by 100 · see citing works
Stewart, J. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00535.x · Cited by 97 · see citing works
Gender and stimulus difference in cue-induced responses in abstinent heroin users
Yu, J., Zhang, S., Epstein, D. H., Fang, Y., Shi, J., Qin, H., Yao, S.-J., Foll, B. L., & Lü, L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.01.008 · Cited by 94 · see citing works
Fatseas, M., Denis, C., Massida, Z., Verger, M., Franques-Rénéric, P., & Auriacombe, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.015 · Cited by 94 · see citing works
Cue Reactivity in Alcohol and Tobacco Dependence
Drobes, D. J. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02506.x · Cited by 84 · see citing works
Schlauch, R. C., Gwynn-Shapiro, D., Stasiewicz, P. R., Molnar, D. S., & Lang, A. R. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.12.003 · Cited by 80 · see citing works
Cue-reactivity and the future of addiction research.
Carter, B. L., & Tiffany, S. T. (1999) · PubMed · Cited by 74 · see citing works
Powell, J. E., Gray, J. A., Bradley, B. P., Kasvikis, Y., Strang, J., Barratt, L., & Marks, I. M. (1990) · Addictive Behaviors · doi:10.1016/0306-4603(90)90044-x · Cited by 73 · see citing works
Tobacco craving predicts lapse to smoking among adolescent smokers in cessation treatment
Bagot, K. S., Heishman, S. J., & Moolchan, E. T. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701365178 · Cited by 69 · see citing works
Garland, E. L., Carter, K., Ropes, K., & Howard, M. O. (2012) · Biological Psychology · doi:10.1016/j.biopsycho.2011.09.010 · Cited by 62 · see citing works
Cue-elicited craving in heroin addicts at different abstinent time: An fMRI pilot study
Lou, M., Wang, E., Shen, Y., & Wang, J. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2011.646381 · Cited by 61 · see citing works
Cue reactivity in non-daily smokers
Shiffman, S. S., Dunbar, M. S., Kirchner, T., Li, X., Tindle, H. A., Anderson, S., Scholl, S. M., & Ferguson, S. G. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2909-4 · Cited by 54 · see citing works
Pain and motives for use among non‐treatment seeking individuals with prescription opioid dependence
Barth, K. S., Maria, M. M. M., Lawson, K. M., Shaftman, S. R., Brady, K. T., & Back, S. E. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12038.x · Cited by 46 · see citing works
Self-citationFischer, B., Nakamura, N., Rush, B. R., Rehm, J. T., & Urbanoski, K. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.001 · Cited by 44 · see citing works
The Cue Reactivity Paradigm in Addiction Research
Reynolds, E. K., & Monti, P. M. (2013) · Wiley eBooks · doi:10.1002/9781118384404.ch14 · Cited by 32 · see citing works
Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts
Shi, J., Jun, W., Zhao, L.-Y., Xue, Y.-X., Zhang, X.-Y., Kosten, T. R., & Lu, L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.011 · Cited by 31 · see citing works
Mainz, V. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00092 · Cited by 30 · see citing works
Cue reactivity as a predictor of successful abstinence initiation among adult smokers.
Conklin, C. A., Parzynski, C. S., Salkeld, R. P., Perkins, K. A., & Fonte, C. A. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029599 · Cited by 29 · see citing works
Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review
Modesto‐Lowe, V., & Kranzler, H. R. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.941116393.x · Cited by 28 · see citing works
Will peak provoked craving prove superior to cue–reactivity?
Adams, S. H., & Munafo, M. R. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04063.x · Cited by 3 · see citing works
Craving by imagery cue reactivity in opiate dependence following detoxification.
Behera, D., Goswami, U., Khastgir, U., & Kumar, S. (2003) · PubMed Central · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00592 · Cited by 140 · see citing works
Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats
Neelakantan, H., Holliday, E. D., Fox, R. G., Stutz, S. J., Comer, S. D., Haney, M., Anastasio, N. C., Moeller, F. G., & Cunningham, K. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00413 · Cited by 90 · see citing works
Carreiro, S., Chintha, K. K., Shrestha, S., Chapman, B. P., Smelson, D. A., & Indic, P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107929 · Cited by 74 · see citing works
The Cambridge Handbook of Substance and Behavioral Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591 · Cited by 63 · see citing works
Reed, D. D., Naudé, G. P., Gelino, B. W., & Amlung, M. T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.011 · Cited by 48 · see citing works
The Prevention and Treatment of Gambling Disorders: Some Art, Some Science
Derevensky, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.024 · Cited by 45 · see citing works
Srey, C. S., Maddux, J.-M. N., & Chaudhri, N. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00054 · Cited by 46 · see citing works
Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
Blum, A. W., & Grant, J. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.038 · Cited by 44 · see citing works
Neurobiological Foundations of Behavioral Addictions
Vaccaro, A. G., & Potenza, M. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.016 · Cited by 45 · see citing works
Neurobiology of Substance Addictions
Christie, N. C., & Bechara, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.015 · Cited by 44 · see citing works
Sensitization of Incentive Salience and the Transition to Addiction
Warlow, S. M., Baumgartner, H. M., Freeland, C. M., Naffziger, E. E., Olney, J. J., Berridge, K. C., & Robinson, M. J. F. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.006 · Cited by 45 · see citing works
Laboratory-induced stress and craving among individuals with prescription opioid dependence
Back, S. E., Grös, D. F., Price, M., LaRowe, S. D., Flanagan, J. C., Brady, K. T., Davis, C., Jaconis, M., & McCauley, J. L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.019 · Cited by 46 · see citing works
Self-citationMindfulness-Based Interventions Applied to Addiction Treatments
Kechter, A., & Black, D. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.040 · Cited by 43 · see citing works
Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science
Stacy, A. W., Pike, J. R., & Lee, A. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.017 · Cited by 43 · see citing works
Tanning as an Addiction: The State of the Research and Implications for Intervention
Miller, K. A., & Mays, D. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.037 · Cited by 43 · see citing works
Schulte, E. M., Schiestl, E. T., & Gearhardt, A. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.035 · Cited by 43 · see citing works
Stress and opioid use disorder: A systematic review
MacLean, R. R., Armstrong, J. L., & Sofuoglu, M. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.05.034 · Cited by 43 · see citing works
Behavioral Economics and Addictive Disorders
Jarmolowicz, D. P., & Schneider, T. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.005 · Cited by 42 · see citing works
Prevention and Treatment of Compulsive Buying Disorder
Galimov, A., & Black, D. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.027 · Cited by 42 · see citing works
Blum, K., Roy, A. K., Podesta, A., Modestino, E. J., Steinberg, B., Gondré-Lewis, M. C., Baron, D. A., Thanos, P. K., Lott, L., Badgaiyan, S., et al. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.031 · Cited by 42 · see citing works
Prevention and Treatment of “Food Addiction”
Davis, C., & Mason, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.023 · Cited by 42 · see citing works
Human Neurobiological Approaches to Hedonically Motivated Behaviors
Burger, K. S., Shearrer, G. E., & Sadler, J. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.009 · Cited by 42 · see citing works
Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools
Griffiths, M. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.034 · Cited by 42 · see citing works
Physiological Indicators of Pathologic Video Game Use in Adolescence
Coyne, S. M., Dyer, W. J., Densley, R. L., Money, N. M., Day, R. D., & Harper, J. M. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.10.271 · Cited by 40 · see citing works
Tan, H., Chen, T., Du, J., Li, R., Jiang, H., Deng, C.-L., Song, W., Xu, D., & Zhao, M. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.09.003 · Cited by 34 · see citing works
Gazi, A. H., Harrison, A. B., Lambert, T. P., Obideen, M., Alavi, P., Murrah, N. V., Shallenberger, L. H., Driggers, E. G., Ortega, R. A., Washington, B. P., et al. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.08.017 · Cited by 30 · see citing works
Self-citationBaker, A. K., & Garland, E. L. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000225 · Cited by 21 · see citing works
Insights into the Neurobiology of Craving in Opioid Use Disorder
Lueptow, L. M., Shashkova, E., Miller, M. G., Evans, C. J., & Cahill, C. M. (2020) · Current anesthesiology reports · doi:10.1007/s40140-020-00420-7 · Cited by 19 · see citing works
Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity
Hanley, A. W., & Garland, E. L. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108351 · Cited by 19 · see citing works
Bergeria, C. L., Gipson, C. D., Smith, K. E., Stoops, W. W., & Strickland, J. C. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105618 · Cited by 16 · see citing works
A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder
Ward, H. B., Mosquera, M. J., Suzuki, J., & Mariano, T. Y. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13108 · Cited by 16 · see citing works
Price, J. L., Bates, M. E., Morgano, J., Todaro, S. M., Uhouse, S. G., Vaschillo, E. G., Vaschillo, B., Pawlak, A. P., & Buckman, J. F. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107207 · Cited by 17 · see citing works
Saraiya, T. C., Jarnecke, A. M., Jones, J. L., Brown, D. G., Brady, K. T., & Back, S. E. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108755 · Cited by 14 · see citing works
Self-citationAppetitive Needs and Addiction
Sussman, S. Y., & Pakdaman, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.004 · Cited by 12 · see citing works
Gazi, A. H., Harrison, A. B., Lambert, T. P., Nawar, A., Obideen, M., Driggers, E. G., Vaccarino, V., Shah, A. J., Rozell, C. J., Bikson, M., et al. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1031368 · Cited by 12 · see citing works
Gilmore, A. K., Jones, J. L., Moreland, A. D., Hahn, C. K., Brady, K. T., & Back, S. E. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.016 · Cited by 11 · see citing works
Self-citationBedford, C. E., Nakamura, Y., Marchand, W. R., & Garland, E. L. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114394 · Cited by 9 · see citing works
Realize, Analyze, Engage (RAE): A Digital Tool to Support Recovery from Substance Use Disorder
Carreiro, S., Taylor, M., Shrestha, S., Reinhardt, M., Gilbertson, N., & Indic, P. (2021) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20210002 · Cited by 11 · see citing works
Qualitative Approaches to the Study of Substance and Behavioral Addictions
Simpson, K. A., & Bluthenthal, R. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.013 · Cited by 8 · see citing works
Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder
Bremner, J. D. (2023) · Annals of Depression and Anxiety · doi:10.26420/anndepressanxiety.2023.1117 · Cited by 7 · see citing works
Learning from addiction: Craving of prescription opioids in chronic pain sufferers
Strigo, I. A., Murphy, E., Mitchell, J., & Spadoni, A. D. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104904 · Cited by 7 · see citing works
Can the incentive-sensitization theory of addiction incorporate addiction to opioid drugs?
Robinson, T. E., & Berridge, K. C. (2026) · Psychopharmacology · doi:10.1007/s00213-025-07001-8 · Cited by 4 · see citing works
Sex and drug differences in stress, craving and cortisol response to the trier social stress task
Baker, N. L., Neelon, B., Ramakrishnan, V., Brady, K. T., Gray, K. M., Saladin, M. E., Back, S. E., Flanagan, J. C., Guille, C., & McRae‐Clark, A. L. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06163-z · Cited by 7 · see citing works
Self-citationMaladaptive Memory Mechanisms in Addiction and Relapse
Rich, M. T., & Torregrossa, M. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00008-7 · Cited by 6 · see citing works
Exploring Exercise- and Context-Induced Peptide Changes in Mice by Quantitative Mass Spectrometry
Dowd, S. E., Mustroph, M. L., Romanova, E. V., Southey, B. R., Pinardo, H., Rhodes, J. S., & Sweedler, J. V. (2018) · ACS Omega · doi:10.1021/acsomega.8b01713 · Cited by 6 · see citing works
Substance and Behavioral Addictions Assessment Instruments
Grigsby, T. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.012 · Cited by 5 · see citing works
Gazi, A. H., Harrison, A. B., Lambert, T. P., Obideen, M., Welsh, J. W., Vaccarino, V., Shah, A. J., Back, S. E., Rozell, C. J., Bremner, J. D., et al. (2022) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi56158.2022.9926787 · Cited by 5 · see citing works
Self-citationCraving-induced effects of different drug cues on persons abstaining from heroin
Yang, T., Zhao, X., Zhang, F., Li, X., Zhu, H., Zhang, M., & Shen, M. (2018) · Addiction Research & Theory · doi:10.1080/16066359.2018.1496425 · Cited by 4 · see citing works
Prevention and Treatment of Sex Addiction
Reid, R. C., Grubbs, J. B., & Kraus, S. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.025 · Cited by 4 · see citing works
Kaysen, D. L., Jaffe, A. E., Shoenberger, B., Walton, T., Pierce, A. R., & Walker, D. D. (2022) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.22-00011 · Cited by 4 · see citing works
Rahman, F. N., Nawar, A., Nye, J. A., Choi, J., Lambert, T. P., Robinson, M., Gazi, A. H., Abbaraju, V., Tomic, N., Harrison, A. B., et al. (2025) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.04.012 · Cited by 3 · see citing works
Examining Brain Networks in Prescription Opioid Users
Ray, S. (2017) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000e137 · Cited by 3 · see citing works
Gaming Disorder and Its Treatment
Griffiths, M. D., Kuss, D. J., & Pontes, H. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.029 · Cited by 4 · see citing works
A pilot study of benzodiazepine cue-induced craving
McHugh, R. K., Korte, F. M., McCarthy, M. D., & Geyer, R. B. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109443 · Cited by 3 · see citing works
Treatment of Alcohol, Tobacco, and Other Drug (ATOD) Misuse
Sussman, S. Y., & Bolshakova, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.022 · Cited by 3 · see citing works
The Role of Culture in Addiction
Hoffman, B. R., & Unger, J. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.018 · Cited by 3 · see citing works
Luba, R. R., & Comer, S. D. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103709 · Cited by 2 · see citing works
Passionate Love Addiction: An Evolutionary Survival Mechanism That Can Go Terribly Wrong
Bolshakova, M., Fisher, H. E., Aubin, H., & Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.026 · Cited by 2 · see citing works
Philosophical Issues in the Addictions
Glackin, S. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.007 · Cited by 2 · see citing works
Vujanovic, A. A., Webber, H. E., Wardle, M. C., Green, C. E., Lane, S. D., & Schmitz, J. M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107211 · Cited by 2 · see citing works
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.020 · Cited by 2 · see citing works
Price, J. L., Bates, M. E., Pawlak, A. P., Uhouse, S. G., Todaro, S. M., Morgano, J., & Buckman, J. F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.945751 · Cited by 1 · see citing works
Prevention and Treatment of Work Addiction
Quiñones, C., & Griffiths, M. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.028 · Cited by 1 · see citing works
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.003 · Cited by 1 · see citing works
Sokhadze, E. M., & Shaban, M. (2022) · NeuroRegulation · doi:10.15540/nr.9.1.16 · Cited by 1 · see citing works
Adolescent Drug Misuse Prevention: Challenges in School-Based Programming
Scheier, L. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.021 · Cited by 1 · see citing works
Measurement, Prevention, and Treatment of Exercise Addiction
Hausenblas, H. A., Mann, D. T. Y., & Downs, D. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.036 · Cited by 1 · see citing works
Tan, H., Chen, T., Du, J., Jiang, H., Deng, C.-L., Song, W., Xu, D., & Zhao, M. (2018) · JMIR Mental Health · doi:10.2196/12092
Compton, W. M., & Blanco, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.001
Novel Psychoactive Substances: A New Challenge for Prevention and Treatment
Kapitány‐Fövény, M., Corazza, O., Marrinan, S., & Demetrovics, Z. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.032
Human Laboratory Paradigms in Addictions Research
Morris, V. L., Arshad, F., Balodis, I. M., Reed, D. D., MacKillop, J. M., & Amlung, M. T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.010
Anhedonia in Addictive Behaviors
Dyer, W. G., Leventhal, A. M., Goldenson, N. I., & Bello, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.039
American Legal Issues in Addiction Treatment and Research
Willick, D. H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.041
Strack, R. W., Orsini, M. M., Ewald, D. R., & Scheier, L. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.019
Clinical and Research Methods in the Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.008
Levels of Analysis and Etiology
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.014
Ongoing and Future Research Directions
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.030
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.002
Srivastava, A. B., & Gold, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.033
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.042
Bremner, J. D., Gazi, A. H., Gurel, N. Z., Lambert, T. P., Wittbrodt, M. T., Welsh, J. W., Pearce, B. D., Vaccarino, V., Shah, A. J., & Inan, O. T. (2026) · Stress · doi:10.1080/10253890.2026.2726826
- Authors
- Back, S. E., Gros, D. F., McCauley, J. L., Flanagan, J. C., Cox, E., Barth, K. S., & Brady, K. T.
- Affiliations
- Medical University of South Carolina (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Back, Sudie E.
- ORCID
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 39
- Issue
- 8
- Pages
- 1217-1223
- ISSN
- 0306-4603 (ISSN-L)
- PMC
- PMC4059191
- OpenAlex
- W2033010168
- Semantic Scholar
- 22a38664167bf5e69e09624846b5b06a287ea9a5
- Cited by
- 81
- References
- 69
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 10 · 2021: 4 · 2020: 47 · 2019: 3 · 2018: 6 · 2017: 2 · 2015: 3
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Addictive Behaviors (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Veterans Affairs (RR029882)
- National Institutes of Health (RR029882)
- National Institute on Drug Abuse (DA021228, HD055885, K12 DA031974, K23DA021228, R25DA020537, K12DA031794)
- National Center for Research Resources (UL1RR029882)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD055885)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- prescription opioid dependence, drug cue reactivity, craving, relapse risk, physiological arousal, salivary cortisol, heart rate, skin conductance, blood pressure, paraphernalia, OxyContin
- MeSH terms
- Adult, Blood Pressure, Cues, Emotions, Female, Galvanic Skin Response, Heart Rate, Humans, Hydrocortisone, Male, Middle Aged, Opioid-Related Disorders, Surveys and Questionnaires, Saliva, Stress, Psychological, Case-Control Studies, Behavior, Addictive, Prescription Drugs, Young Adult, Craving
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review